Mabion launches €500,000 services contest to support oncology breakthroughs 

“Despite unprecedented scientific advances, many oncology treatments still face hurdles at the funding stage,” said Julita Balcerek, Ph.D., COO at Mabion. “This contest is our invitation to innovators who just need the right partner. We’re offering more than a prize; we’re offering a path to impact”.

Selected entrants will be guided through pre-qualification, NDAs, and proposal shaping with Mabion’s business development team. An independent jury of experts will evaluate entries based on scientific merit, feasibility, and potential patient impact:

• Prof. Tadeusz Pietrucha, Medical Biotechnology Department at Medical University of Łódź – Translational Oncology Expert
• Prof. Przemysław Juszczyński, Department of Experimental Hematology and Transfusionology at Lazarski University – Scientific Innovation Specialist
• Prof. Gestur Vidarsson. PI and head of Immunoglobulin Research at Sanquin Research at the Utrecht University and Chair of the Immunoglobulin Biotherapeutics group – Leading Expert in Immunoglobulin-based Biotherapeutics
• Alicja Santos, Ph.D., CEO of Polonium Foundation – Biotech Talent Advocate
• Julita Balcerek, Ph.D., COO of Mabion – CDMO Strategy Leader

The winner will receive a €500,000 credit toward Mabion’s integrated CDMO capabilities, including process and analytical development, upstream/downstream processing, and clinical supply manufacturing. Runner-up entries may also be invited into partnership discussions, reinforcing Mabion’s focus on long-term collaboration.

“Wherever you’re based, this is your chance to accelerate your breakthrough program with Mabion’s financial support and world class services,” Balcerek added. “Mabion is proud to help turn scientific ambition into clinical reality.”